Register Interest

Optiscan Imaging Limited

  • OptiScan (ASX:OIL) has developed imaging technology for use in Cancer Screening and Surgery, providing an instantaneous “digital” biopsy.
  • Our technology forms part of the ZEISS CONVIVO™, developed in collaboration with Carl Zeiss Meditec, a leading German medical technology company for use in Brain Cancer. We are seeking approval in the US for our InVivage™ device in Oral Cancer.